|
|
|
The role of nutrition in martial arts, police, military personnel
Copyright 2005 Internet Publications For a considerable amount of time, nutrition has not played a prominent role in the life of many martial artists, police, and military personnel as a means of improving performance. Top athletes are always...
|
Kanhaiya Amla Powder
AMLA (EMBLICA OFFICINALIS) FOR HEALTH AND BEAUTY
AMLA, proudly known as 'Indian Gooseberry' has been the key constituent of many Ayurvedic formulations. And nowadays, it has been accepted by almost all medical branches as a result of...
Serious About Wanting To Improve Your Family's Healthy Eating Lifestyles?
PERMISSION TO REPUBLISH: This article may be republished in newsletters and on web sites provided attribution is provided to the author, and it appears with the included copyright, resource box and live web site link. Email notice of intent to...
|
|
Understanding hair loss and what you can do about it
As you are quite aware hair loss is quite normal. Often as some
hairs fall out, others replace it. Sometimes this can however
due to a few conditions. Factors like hormonal changes, stress,
poor diet, emotional TRAMA are just to name a few. As...
|
|
|
Eli Lilly to pay $700 million to Zyprexa Victims
Eli Lilly to pay $700 million to Zyprexa Victims
On June 9th, 2005 Eli Lilly and Company announced that it has entered an agreement with plaintiffs’ attorneys involved in Zyprexa liability litigation to settle most of the claims against the company relating to their Zyprexa medication.
"While we believe the claims are without merit, we took this difficult step because we believe it is in the best interest of the company, the patients who depend on this medication, and their doctors," said Sidney Taurel, chairman, president and chief executive officer of Eli Lilly and Company.
The agreement states that Eli Lilly will establish a fund of $690 million for plaintiffs who agree to settle their claims. This settlement fund will be overlooked and distributed by claims administrators chosen by the steering committee of the plaintiffs. At this time the number of claimants is projected at around 8,000 comprising about 75% of claims identified to
Lilly.
This agreement involves claimants who have allegedly developed diabetes-related side effects from their use of the drug Zyprexa. Those who are not covered by the final settlement are those who are represented by attorneys not participating in the agreement in principle. Lilly is ready to continue their forceful defense of Zyprexa in the remaining cases.
Investors have been advised that at least $700 million pretax will be taken in the 2nd quarter of 2005 to cover this settlement and as well as other product liability claims.
To learn more about this recent Zyprexa settlement by Eli Lilly and Company please visit http://www.resource4zyprexainfo.com
About the Author
This article may be freely re-printed as long as this resource box is included and all links stay intact as hyper-links. To learn more about hiring a Zyprexa lawyer please visit http://www.resource4zyprexainfo.com
|
|
|
|
|
|
